The state of the hunt:Pfizer/BioNTech’s vaccine won U.S. FDA Emergency Use Authorization.
The inactivated vaccine from CNBG’s Beijing subsidiary secured UAE registration.
Bharat Biotech and SII requested Indian authorization of their respective jabs.
Approved or authorized vaccines
The Pfizer/BioNTech vaccine extended its regulatory lead this week with new authorizations, including a U.S. nod.